These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
486 related articles for article (PubMed ID: 26987992)
1. Current status and future of clinical islet xenotransplantation. Matsumoto S; Tomiya M; Sawamoto O J Diabetes; 2016 Jul; 8(4):483-93. PubMed ID: 26987992 [TBL] [Abstract][Full Text] [Related]
2. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Executive summary. Hering BJ; Cozzi E; Spizzo T; Cowan PJ; Rayat GR; Cooper DK; Denner J Xenotransplantation; 2016; 23(1):3-13. PubMed ID: 26940725 [TBL] [Abstract][Full Text] [Related]
3. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria. Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763 [TBL] [Abstract][Full Text] [Related]
4. Current situation of clinical islet transplantation from allogeneic toward xenogeneic. Matsumoto S; Shimoda M J Diabetes; 2020 Oct; 12(10):733-741. PubMed ID: 32246528 [TBL] [Abstract][Full Text] [Related]
5. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 1: update on national regulatory frameworks pertinent to clinical islet xenotransplantation. Cozzi E; Tönjes RR; Gianello P; Bühler LH; Rayat GR; Matsumoto S; Park CG; Kwon I; Wang W; O'Connell P; Jessamine S; Elliott RB; Kobayashi T; Hering BJ Xenotransplantation; 2016; 23(1):14-24. PubMed ID: 26940509 [TBL] [Abstract][Full Text] [Related]
6. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 2a: source pigs--preventing xenozoonoses. Spizzo T; Denner J; Gazda L; Martin M; Nathu D; Scobie L; Takeuchi Y Xenotransplantation; 2016; 23(1):25-31. PubMed ID: 26940608 [TBL] [Abstract][Full Text] [Related]
7. Clinical Islet Xenotransplantation: Development of Isolation Protocol, Anti-Rejection Strategies, and Clinical Outcomes. Matsumoto S; Matsumoto K Cells; 2024 May; 13(10):. PubMed ID: 38786050 [TBL] [Abstract][Full Text] [Related]
8. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Denner J; Schuurman HJ; Patience C Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764 [TBL] [Abstract][Full Text] [Related]
9. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 6: patient selection for pilot clinical trials of islet xenotransplantation. Hering BJ; O'Connell PJ Xenotransplantation; 2016; 23(1):60-76. PubMed ID: 26918540 [TBL] [Abstract][Full Text] [Related]
10. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 6: Patient selection for pilot clinical trials of islet xenotransplantation. O'Connell PJ Xenotransplantation; 2009; 16(4):249-54. PubMed ID: 19799765 [TBL] [Abstract][Full Text] [Related]
11. Microencapsulation in Clinical Islet Xenotransplantation. Shimoda M; Matsumoto S Methods Mol Biol; 2017; 1479():335-345. PubMed ID: 27738947 [TBL] [Abstract][Full Text] [Related]
12. Clinical porcine islet xenotransplantation under comprehensive regulation. Matsumoto S; Tan P; Baker J; Durbin K; Tomiya M; Azuma K; Doi M; Elliott RB Transplant Proc; 2014; 46(6):1992-5. PubMed ID: 25131091 [TBL] [Abstract][Full Text] [Related]
13. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 3: Pig islet product manufacturing and release testing. Korbutt GS Xenotransplantation; 2009; 16(4):223-8. PubMed ID: 19799762 [TBL] [Abstract][Full Text] [Related]
14. Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand. Wynyard S; Nathu D; Garkavenko O; Denner J; Elliott R Xenotransplantation; 2014; 21(4):309-23. PubMed ID: 24801820 [TBL] [Abstract][Full Text] [Related]
15. Clinical Benefit of Islet Xenotransplantation for the Treatment of Type 1 Diabetes. Matsumoto S; Abalovich A; Wechsler C; Wynyard S; Elliott RB EBioMedicine; 2016 Oct; 12():255-262. PubMed ID: 27592597 [TBL] [Abstract][Full Text] [Related]
16. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 5: recipient monitoring and response plan for preventing disease transmission. Denner J; Tönjes RR; Takeuchi Y; Fishman J; Scobie L Xenotransplantation; 2016; 23(1):53-9. PubMed ID: 26918415 [TBL] [Abstract][Full Text] [Related]
18. Xenoislets: porcine pancreatic islets for the treatment of type I diabetes. Mourad NI; Gianello PR Curr Opin Organ Transplant; 2017 Dec; 22(6):529-534. PubMed ID: 28915137 [TBL] [Abstract][Full Text] [Related]
19. Pig islet xenotransplantation. Dhanasekaran M; George JJ; Loganathan G; Narayanan S; Hughes MG; Williams SK; Balamurugan AN Curr Opin Organ Transplant; 2017 Oct; 22(5):452-462. PubMed ID: 28759462 [TBL] [Abstract][Full Text] [Related]
20. Current status of islet xenotransplantation. Park CG; Bottino R; Hawthorne WJ Int J Surg; 2015 Nov; 23(Pt B):261-266. PubMed ID: 26253846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]